Abstracts tagged "Magnetic resonance imaging (MRI) and seronegative spondyloarthropathy"

Abstract Number: 1569 • 2017 ACR/ARHP Annual Meeting
Isotretinoin Induced Seronegative Spondyloarthropathy: Magnetic Resonance Imaging As Diagnostic and Prognostic Biomarker
Basant Elnady^1,2, Dalia Desouky^3,4, Tohamy Elkhouly^5,6, Noha Dawoud^7,8 and Hanady Kewan^9,10, ¹Assistant professor of rheumatology and rehabilitation, department of rheumatology and rehabilitation ، faculty of medicine, Benha university, Benha, Egypt, ²Rheumatology consultant ,Rheumatology division ,Al Hada Armed Forcec Hospital, Taif, Saudi Arabia, ³Assistant professor of public health and community medicine,department of public health and community medicine,Faculty of medicine, menoufia University, menoufia, Egypt, ⁴Assistant professor of public health and community medicine, department of family and community medicine، faculty of medicine, taif university, Taif, Saudi Arabia, ⁵Assistant professor of radiology, radiology department ، faculty of medicine, Benha university, Benha, Egypt, ⁶Radiology consultant , Department of radiology ,Alhada Armed Forces Hospital, Taif, Saudi Arabia, ⁷department of dermatology , andrology, and STDs, faculty of medicine, Menoufia university, menoufia, Egypt, ⁸department of dermatology, Alhada armed forces hospital, Tafi, Ksa, taif, Saudi Arabia, ⁹Department of radio-diagnosis, Faculty of medicine, Mansoura University., Mansoura, Egypt, ¹⁰Radiology consultant ,Department of radiology, Al Hada Armed Forces Hopital, taif, Saudi Arabia
Background/Purpose: Recent data has revealed occurrence of musculoskeletal manifestations in particular sacroiliitis and inflammatory back pain (IBP) secondary to isotretinoin therapy for acne valgaris, accordingly…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].